(Q34240820)

31 July 2017

1 reference

title

Current and future treatment of Lyme disease (English)

1 reference

31 July 2017

0 references

Ravishankar J

1

1 reference

PubMed ID

11336583

31 July 2017

Lutwick LI

series ordinal

2

1 reference

PubMed ID

11336583

31 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

Expert Opinion on Pharmacotherapy

31 July 2017

1 reference

31 July 2017

2

1 reference

31 July 2017

2

1 reference

31 July 2017

241-251

1 reference

Lyme disease during pregnancy

31 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.2.241

Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.2.241

Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.2.241

Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.2.241

Penicillin G sodium and ceftriaxone in the treatment of neuroborreliosis in children--a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.2.241

Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.2.241

Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.2.241

Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.2.241

Insect repellents: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.2.241

Efficacy of antibiotic prophylaxis for prevention of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.2.241

Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.2.241

Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.2.241

Induction of an outer surface protein on Borrelia burgdorferi during tick feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.2.241

A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.2.241

Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.2.241

The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.2.241

21 January 2018

Identifiers

DOI

10.1517/14656566.2.2.241

1 reference

31 July 2017

1 reference

PubMed ID

11336583